Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals-Reference-Cited by-同舟云学术

Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals

Published:2024-07-11 Issue: Volume: Page:
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Lunghi Carlotta^ORCID,Domenicali Marco^ORCID,Vertullo Stefano,Raschi Emanuel^ORCID,De Ponti Fabrizio^ORCID,Onder Graziano^ORCID,Poluzzi Elisabetta^ORCID

Funder

Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement

Alma Mater Studiorum - Università di Bologna

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40264-024-01453-1.pdf

Reference100 articles.

1. O’Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart J-B, Onder G, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med [Internet]. 2023. https://doi.org/10.1007/s41999-023-00777-y.

2. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.

3. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.

4. Gaubert-Dahan M-L, Sebouai A, Tourid W, Fauvelle F, Aikpa R, Bonnet-Zamponi D. The impact of medication review with version 2 STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria in a French nursing home: a 3-month follow-up study. Ther Adv Drug Saf. 2019;10:2042098619855535.

5. Sallevelt BTGM, Huibers CJA, Heij JMJO, Egberts TCG, van Puijenbroek EP, Shen Z, et al. Frequency and acceptance of clinical decision support system-generated STOPP/START signals for hospitalised older patients with polypharmacy and multimorbidity. Drugs Aging. 2022;39:59–73.